Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 30 | 27 | −3 |
| Shares | 3.41M | 2.96M | −448.6K (−13.2%) |
| Value | $10.6M | $11.8M | +$1.14M (+10.8%) |
New holders (4)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 341,087 | $1.36M | 0.02% |
| Marshall Wace, LLP | 48,137 | $191.6K | 0.00% |
| Susquehanna International Group, LLP | 26,038 | $103.6K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $796 | 0.00% |
Sold out (7)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Millennium Management LLC | 598,634 | $1.87M |
| XTX Topco Ltd | 10,591 | $33.0K |
| Group One Trading, L.P. | 7,742 | $24.2K |
| Tower Research Capital LLC (TRC) | 787 | $2.46K |
| Jones Financial Companies LLLP | 600 | $1.85K |
| Farther Finance Advisors, LLC | 345 | $1.08K |
| Citigroup Inc | 4 | $12 |